KNG
FT Cboe Vest S&P 500® Dv Ast Tgt Inc ETF
CBOE S&P500 Div Arstcrts Tgt Inc TR USD
NAV as of
4 Week: 49.42 - 52.23
52 Week: 45.60 - 56.45
Latest Closing Price
50.48
Premium / Discount
-0.06
Expense Ratio
0.75%
Investment Objective
The investment seeks investment results that correspond generally to the price and yield of an equity index called the Cboe S&P 500® Dividend Aristocrats Target Income Index Monthly Series. The fund invests at least 80% of its total assets in the common stocks and call options that comprise the index. The index is designed with the primary goal of generating an annualized level of income from stock dividends and option premiums that is approximately 3% over the annual dividend yield of the S&P 500® Index and a secondary goal of generating capital appreciation based on the price returns of the equity securities contained in the index.
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -1.19 | 0.97 | -1.23 |
| 1 Day | 0.96 | 0.00 | 0.00 |
| 1 Week | 0.38 | 2.93 | 0.13 |
| 1 Month | -2.30 | 4.36 | -0.53 |
| 3 Months | -2.90 | 7.58 | -0.38 |
| 6 Months | 4.06 | 14.09 | 0.29 |
| 1 Year | -7.63 | 19.24 | -0.40 |
| 2 Years | 0.08 | 23.03 | 0.00 |
| 3 Years | 54.17 | 34.83 | 1.56 |
| 5 Years | 0.00 | 0.00 | 0.00 |
| 10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 25.8819 | 7.3031 | 24.3911 | -6.8824 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 83.0000 | 93.0000 | 71.0000 | 60.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 22/12/2022 | 29/12/2022 | 0.5286 |
| 22/09/2022 | 29/09/2022 | 0.5019 |
| 23/06/2022 | 29/06/2022 | 0.4995 |
| 24/03/2022 | 30/03/2022 | 0.5155 |
| 22/12/2021 | 30/12/2021 | 0.5063 |
| 22/09/2021 | 29/09/2021 | 0.4910 |
| 23/06/2021 | 29/06/2021 | 0.4965 |
| 24/03/2021 | 30/03/2021 | 0.4804 |
| 28/12/2020 | 30/12/2020 | 0.4620 |
| 24/03/2020 | 26/03/2020 | 0.3941 |
Portfolio Data
Total Number of Holdings: 68
Number of Bond Holdings: 0
Number of Equity Holdings: 66
Total Market Value: 576,323,724
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | West Pharmaceutical Services Inc | 1.8939 | 34,757 | 581 | 11,062,458 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 18.07 |
| Large | 36.71 |
| Medium | 44.46 |
| Small | 0.00 |
| Micro | 0.00 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
18.9432
Price/Book*
3.1157
Price/Sales*
1.2871
Price/Cash Flow*
11.6139
Dividend Yield*
2.4985
Growth Measures
Long-Term Earnings
12.5428
Historical Earnings
17.2228
Sales Growth
10.6215
Cash-Flow Growth
4.7019
Book-Value Growth
5.9596
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
